CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 18 enrolled
Drug / intervention
Wearable vibration belt +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03688282
NCT03688282N/ACompleted

Wearable Vibration Device to Prevent Bone Loss in Postmenopausal Women--Aim 2

Theranova, L.L.C.·interventional·Posted Sep 28, 2018·Updated Apr 27, 2021

In Brief

A clinical study evaluating Wearable vibration belt and Sham, wearing belt for Osteopenia. Completed, enrolled 18 participants across 1 site.

Detailed Summary

The wearable vibration device aims to consistently deliver vibrations directly to the hip and spine and allowing use during many everyday activities. We propose that demonstrating higher rates of compliance and consistent delivery of optimal force, with accelerometer feedback, will provide a superior alternative to whole body vibration and is plausibly more effective at preventing bone loss in postmenopausal women than vibration platforms in the home setting.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteopenia
CountriesUnited States

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedSep 28, 2018
Enrollment StartJul 11, 2018
Primary CompletionNov 29, 2018
Study CompletionApr 17, 2019
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 7.8 years ago

Interventions

Wearable vibration beltdevice

The device is worn, a wearable vibration belt, for a specified time. This will provide vibration starting at the hips.

Sham, wearing beltdevice

The device is worn, for a specified time. It will not be turned on during this period. It is only sham.